ReviewFrontiers in dental medicine2025
Current insights on the genetics and mechanisms of MSX1-associated cleft palate.
Review in Frontiers in dental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cleft palate, a common congenital anomaly, is characterized by a failure of the palatal shelves to fuse during embryogenesis, resulting in an opening between the oral and nasal cavities. This malformation not only affects facial aesthetics but also significantly impacts speech, feeding, and hearing, necessitating multidisciplinary care from birth through adulthood. The etiology of cleft palate is complex, involving both genetic and environmental factors. Among the numerous genes implicated, Msx1 plays a pivotal role in palatal development. As a transcription factor, Msx1 regulates mesenchymal cell proliferation and epithelial-mesenchymal interactions, processes crucial for proper palatal shelf elevation and fusion. Disruptions in Msx1 expression or function have been directly linked to cleft palate through both animal and human studies, highlighting its significance in palatogenesis. This review focuses on the role of Msx1 in cleft palate, providing a comprehensive overview of its functions and the molecular mechanisms through which it influences palatal development. We examine recent research findings, including studies on Msx1 mutations, signaling pathways, and gene-environment interactions, to elucidate the complex relationship between Msx1 and cleft palate. Moreover, advancing research could establish Msx1 as a fundamental target in the creation of innovative therapeutic strategies for craniofacial disorders. By synthesizing current knowledge, this review aims to provide a deeper understanding of Msx1's role in cleft palate and pave the way for future research and clinical advancements.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.